Home / Research Library / Cancer chemotherapy and beyond: Current status, dr...
🧬 Medicine & Biology OpenAlex

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

📅 March 18, 2022 👤 Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel et al. 📖 Genes & Diseases 📊 1,654 citations

🤖 Plain-English Summary

Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and produce aggressive malignancies that causes millions of deaths every year. Chemotherapeutic agents/pharmaceuticals served a great purpose over the past few decades and have remained the frontline choice for advanced-stage malignancies where surgery and/or radiation therapy cannot be prescribed due to specific reasons.

🔑 Key Findings

  • With the new understanding of the molecular mechanism(s) of disease progression, our knowledge about the disease is snowballing, leading to the evolution of many new therapeutic regimes and their successive trials.
  • In the past few decades, various combinations of therapies have been proposed and are presently employed in the treatment of diverse cancers.
  • Targeted drug therapy, immunotherapy, and personalized medicines are now largely being employed, which were not common a few years back.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Mar 18, 2022
Journal Genes & Diseases
Authors Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, Rupa Sanyal, Amarnath Mishra
DOI 10.1016/j.gendis.2022.02.007
Citations 1,654
Source OpenAlex

More 🧬 Medicine & Biology Research